22 results
6-K
EX-99.1
TRIB
Trinity Biotech Plc
30 Apr 24
Statement of Assets Acquired and Liabilities Assumed
12:28pm
and the user alerted to risks of hypo- or hyperglycaemic episodes.
The Waveform CGM technology contains innovative and proprietary aspects with what … that this innovative platform technology will allow us to develop a broader suite of wearable biosensors to measure and analyse important health
6-K
EX-99.1
TRIB
Trinity Biotech Plc
1 Feb 24
Trinity Biotech Announces Acquisition of the CGM Assets of
11:33am
(“NGOs”) and global health funds to increase adoption of innovative diabetes care tools worldwide,” he concluded.
Approved CGM offers differentiated … below.
The Waveform CGM technology contains innovative and proprietary aspects with important user benefits that include needle-free insertion
6-K
EX-99.2
TRIB
Trinity Biotech Plc
1 Feb 24
Trinity Biotech Announces Acquisition of the CGM Assets of
11:33am
, dietary changes and sedentary lifestyles have contributed to the escalation of Type 2 diabetes across China, creating a pressing need for innovative … . With a low cost of care offering, this partnership intends to increase access to CGM technology across India, providing an innovative and affordable path
6-K
EX-99.1
TRIB
Trinity Biotech Plc
6 Sep 23
This report has been prepared in accordance with the Irish Companies Act 2014
4:04pm
with universities and innovative companies.
The Group’s competition includes several large companies such as, but not limited to: Abbott Diagnostics, Arkray
6-K
EX-99.1
5t6dr
12 Sep 22
This report has been prepared in accordance with the Irish Companies Act 2014
12:31pm
6-K
EX-99.1
5hsm muicza0gwyrb
11 Apr 22
Trinity Biotech Announces A $45 Million Strategic Investment And
8:15am
6-K
EX-99.1
6cbq3 htdumh1
17 Sep 21
This report has been prepared in accordance with the Irish Companies
4:36pm
6-K
4uge0
30 Jul 13
Current report (foreign)
12:00am